A detailed history of Amundi transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Amundi holds 11,240,529 shares of GILD stock, worth $990 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
11,240,529
Previous 9,500,616 18.31%
Holding current value
$990 Million
Previous $696 Million 10.82%
% of portfolio
0.3%
Previous 0.29%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$63.15 - $72.88 $110 Million - $127 Million
1,739,913 Added 18.31%
11,240,529 $771 Million
Q1 2024

May 15, 2024

SELL
$71.58 - $87.29 $73 Million - $89 Million
-1,019,938 Reduced 9.69%
9,500,616 $696 Million
Q4 2023

Feb 14, 2024

SELL
$73.27 - $83.09 $6.02 Million - $6.82 Million
-82,104 Reduced 0.77%
10,520,554 $852 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $23.4 Million - $25.6 Million
-316,824 Reduced 2.9%
10,602,658 $795 Million
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $22.4 Million - $25.5 Million
294,400 Added 2.77%
10,919,482 $842 Million
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $33.8 Million - $38.5 Million
437,302 Added 4.29%
10,625,082 $882 Million
Q4 2022

Feb 14, 2023

SELL
$62.32 - $89.47 $1.33 Million - $1.91 Million
-21,368 Reduced 0.21%
10,187,780 $875 Million
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $127 Million - $145 Million
2,126,205 Added 26.3%
10,209,148 $659 Million
Q2 2022

Aug 15, 2022

BUY
$57.72 - $65.01 $73.2 Million - $82.4 Million
1,267,513 Added 18.6%
8,082,943 $500 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $99.3 Million - $124 Million
-1,714,000 Reduced 20.1%
6,815,430 $412 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $124 Million - $141 Million
-1,914,086 Reduced 18.33%
8,529,430 $613 Million
Q3 2021

Nov 15, 2021

BUY
$67.69 - $73.03 $110 Million - $118 Million
1,617,865 Added 18.33%
10,443,516 $729 Million
Q2 2021

Aug 16, 2021

BUY
$63.47 - $69.35 $560 Million - $612 Million
8,825,651 New
8,825,651 $608 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.